Copyright
©2007 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 28, 2007; 13(40): 5343-5350
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5343
Published online Oct 28, 2007. doi: 10.3748/wjg.v13.i40.5343
Table 2 Factors associated with second recurrence
| Variables | Univariate analysis | Multivariate analysis | ||||
| Hazard ratio | 95% CI | P | Hazard ratio | 95% CI | P | |
| SVR | 0.454 | 0.246-0.728 | 0.0005 | 0.457 | 0.243-0.757 | 0.0015 |
| PLT > 100000/μ | 0.553 | 0.373-0.814 | 0.003 | 0.694 | 0.445-1.069 | 0.0973 |
| ICG R-15 (< 20%) | 0.667 | 0.450-0.965 | 0.032 | 0.685 | 0.447-1.035 | 0.0721 |
- Citation: Jeong SC, Aikata H, Katamura Y, Azakami T, Kawaoka T, Saneto H, Uka K, Mori N, Takaki S, Kodama H, Waki K, Imamura M, Shirakawa H, Kawakami Y, Takahashi S, Chayama K. Effects of a 24-week course of interferon-α therapy after curative treatment of hepatitis C virus-associated hepatocellular carcinoma. World J Gastroenterol 2007; 13(40): 5343-5350
- URL: https://www.wjgnet.com/1007-9327/full/v13/i40/5343.htm
- DOI: https://dx.doi.org/10.3748/wjg.v13.i40.5343